Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans. / Zois, Nora Elisabeth; Terzic, Dijana; Faerch, Kristine; Plomgaard, Peter; Hansen, Jakob S; Rossing, Peter; Gøtze, Jens Peter.

I: EBioMedicine, Bind 17, 2017, s. 88-94.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Zois, NE, Terzic, D, Faerch, K, Plomgaard, P, Hansen, JS, Rossing, P & Gøtze, JP 2017, 'Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans' EBioMedicine, bind 17, s. 88-94. https://doi.org/10.1016/j.ebiom.2017.02.026

APA

Zois, N. E., Terzic, D., Faerch, K., Plomgaard, P., Hansen, J. S., Rossing, P., & Gøtze, J. P. (2017). Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans. EBioMedicine, 17, 88-94. https://doi.org/10.1016/j.ebiom.2017.02.026

Vancouver

Zois NE, Terzic D, Faerch K, Plomgaard P, Hansen JS, Rossing P o.a. Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans. EBioMedicine. 2017;17:88-94. https://doi.org/10.1016/j.ebiom.2017.02.026

Author

Zois, Nora Elisabeth ; Terzic, Dijana ; Faerch, Kristine ; Plomgaard, Peter ; Hansen, Jakob S ; Rossing, Peter ; Gøtze, Jens Peter. / Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans. I: EBioMedicine. 2017 ; Bind 17. s. 88-94.

Bibtex

@article{027d6fe08ae94dbaaad410fb9df9e8cb,
title = "Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans",
abstract = "Plasma concentrations of pro-Atrial natriuretic peptide, proANP, are decreased in obesity and diabetes. Decreased proANP concentrations have also been noted after meal intake, and recently, a glucose-mediated regulation of ANP gene expression was reported. Hence, we evaluated the effects of insulin, glucagon and glucose on plasma proANP in a series of observational and experimental studies. Six healthy men underwent seven days of bed rest. Before and after the bed rest, hyperinsulinemic euglycemic clamps with serial plasma measurements of proANP were performed. Moreover, plasma proANP was quantified in 65 individuals with normal or impaired glucose regulation. Finally, the effects of infusion-induced hyperglucagonemia were examined in ten healthy men. Bed rest decreased insulin sensitivity and plasma proANP. The decrease in proANP was not associated with insulin sensitivity and the peptide concentrations remained constant during euglycemic hyperinsulinemia and hyperglycemic hyperglucagonemia. Impaired glucose regulation was not associated with decreased proANP concentrations. Bed rest per se induces a marked decrease in plasma proANP concentrations whereas insulin resistance and impaired glucose regulation was not associated with lower proANP concentrations. Neither acute hyperinsulinemia nor hyperglucagonemia seems to affect plasma proANP. Our findings thus suggest that decreased plasma proANP concentrations occur late in the development of insulin resistance.",
author = "Zois, {Nora Elisabeth} and Dijana Terzic and Kristine Faerch and Peter Plomgaard and Hansen, {Jakob S} and Peter Rossing and G{\o}tze, {Jens Peter}",
note = "Copyright {\circledC} 2017. Published by Elsevier B.V.",
year = "2017",
doi = "10.1016/j.ebiom.2017.02.026",
language = "English",
volume = "17",
pages = "88--94",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans

AU - Zois, Nora Elisabeth

AU - Terzic, Dijana

AU - Faerch, Kristine

AU - Plomgaard, Peter

AU - Hansen, Jakob S

AU - Rossing, Peter

AU - Gøtze, Jens Peter

N1 - Copyright © 2017. Published by Elsevier B.V.

PY - 2017

Y1 - 2017

N2 - Plasma concentrations of pro-Atrial natriuretic peptide, proANP, are decreased in obesity and diabetes. Decreased proANP concentrations have also been noted after meal intake, and recently, a glucose-mediated regulation of ANP gene expression was reported. Hence, we evaluated the effects of insulin, glucagon and glucose on plasma proANP in a series of observational and experimental studies. Six healthy men underwent seven days of bed rest. Before and after the bed rest, hyperinsulinemic euglycemic clamps with serial plasma measurements of proANP were performed. Moreover, plasma proANP was quantified in 65 individuals with normal or impaired glucose regulation. Finally, the effects of infusion-induced hyperglucagonemia were examined in ten healthy men. Bed rest decreased insulin sensitivity and plasma proANP. The decrease in proANP was not associated with insulin sensitivity and the peptide concentrations remained constant during euglycemic hyperinsulinemia and hyperglycemic hyperglucagonemia. Impaired glucose regulation was not associated with decreased proANP concentrations. Bed rest per se induces a marked decrease in plasma proANP concentrations whereas insulin resistance and impaired glucose regulation was not associated with lower proANP concentrations. Neither acute hyperinsulinemia nor hyperglucagonemia seems to affect plasma proANP. Our findings thus suggest that decreased plasma proANP concentrations occur late in the development of insulin resistance.

AB - Plasma concentrations of pro-Atrial natriuretic peptide, proANP, are decreased in obesity and diabetes. Decreased proANP concentrations have also been noted after meal intake, and recently, a glucose-mediated regulation of ANP gene expression was reported. Hence, we evaluated the effects of insulin, glucagon and glucose on plasma proANP in a series of observational and experimental studies. Six healthy men underwent seven days of bed rest. Before and after the bed rest, hyperinsulinemic euglycemic clamps with serial plasma measurements of proANP were performed. Moreover, plasma proANP was quantified in 65 individuals with normal or impaired glucose regulation. Finally, the effects of infusion-induced hyperglucagonemia were examined in ten healthy men. Bed rest decreased insulin sensitivity and plasma proANP. The decrease in proANP was not associated with insulin sensitivity and the peptide concentrations remained constant during euglycemic hyperinsulinemia and hyperglycemic hyperglucagonemia. Impaired glucose regulation was not associated with decreased proANP concentrations. Bed rest per se induces a marked decrease in plasma proANP concentrations whereas insulin resistance and impaired glucose regulation was not associated with lower proANP concentrations. Neither acute hyperinsulinemia nor hyperglucagonemia seems to affect plasma proANP. Our findings thus suggest that decreased plasma proANP concentrations occur late in the development of insulin resistance.

U2 - 10.1016/j.ebiom.2017.02.026

DO - 10.1016/j.ebiom.2017.02.026

M3 - Journal article

VL - 17

SP - 88

EP - 94

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

ER -

ID: 174399084